Table 2 Comparison of preoperative conditions between two groups of patients
Variables | LSO approach group | Standard pterional approach group | P value |
|---|---|---|---|
Classification | 0.944 | ||
Intrasellar | 0 | 1 | |
Intra-suprasellar | 8 | 13 | |
Intra-suprasellar-intraventricular | 5 | 10 | |
Suprasellar-extraventricular | 5 | 8 | |
Suprasellar-intraventricular | 6 | 9 | |
Intraventricular | 0 | 0 | |
Tumor size (cm) | 3.6 ± 1.39 | 3.3 ± 1.09 | 0.228 |
Sex | 0.519 | ||
Female | 10 | 16 | |
Male | 14 | 25 | |
Age (year) | 52.0 ± 19.67 | 46.6 ± 16.19 | 0.234 |
Pre-operation endocrine disorders | |||
Triiodothyronine | 13 | 14 | 0.128 |
Thyrine | 10 | 13 | 0.435 |
HormotHyrin | 3 | 4 | 0.703 |
Hudrocortisone | 11 | 22 | 0.612 |
Flitropin | 8 | 15 | 1.000 |
Prolan B | 13 | 23 | 1.000 |
Prolactin | 17 | 26 | 0.597 |
Growth hormone | 0 | 1 | 1.000 |